Tag: Onkoloji - Altai Oncology

Altai Protocol Library

1041 protocols and counting

All protocols with references and links

All protocols reviewed by a Medical Oncologist/Hematologist

All protocols in major guidelines included

Ability to create your own protocols

Altai Protocol Library | June 16, 2022

New Indication: Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma

Study: Phase II-III, multicenter, randomized, double-blind, placebo-controlled study (SEAL) Advanced dedifferentiated liposarcoma who received 2-5 lines chemotherapy Selinexor (N: 188) or placebo (N:97) twice weekly in 6-week cycles Efficacy: No

Altai Protocol Library | June 16, 2022

New Reference: Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia

Study: Double-blind, randomized, placebo-controlled, phase 3 trial Newly diagnosed IDH1-mutated acute myeloid leukemia Ineligible for intensive induction chemotherapy Oral ivosidenib and azacitidine (N:72) or placebo and azacitidine (N:74) Efficacy: HR